Endoscopic implantation of Enteryx for treatment of GERD: 12-Month results of a prospective, multicenter trial

American Journal of Gastroenterology

Volumn 98, Issue 9, 2003, Pages 1921-1930

  Johnson, David A ^a   Ganz, Robert ^b   Aisenberg, James ^b   Cohen, Lawrence B ^b   Devière, Jacques ^b   Foley, T Raymond ^b   Haber, Gregory B ^b   Peters, Jeffrey H ^b   Lehman, Glen A ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; DEXTROPROPOXYPHENE; DIMETHYL SULFOXIDE; ETHYLENE VINYL ALCOHOL COPOLYMER; HYDROCODONE; PROTON PUMP INHIBITOR; TANTALUM;

ACIDITY; ADULT; ARTICLE; BIOCOMPATIBILITY; CLINICAL TRIAL; ENDOSCOPIC THERAPY; FEMALE; FLUOROSCOPY; FOLLOW UP; FOOD REGURGITATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; SCORING SYSTEM; STOMACH ACID; SYMPTOM; THORAX PAIN;

EID: 0042717864     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.08109.x     Document Type: Article

References (32)

1. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992;51(suppl I):24-9.
2. Louis E, DeLooze D, Deprez P, et al. Heartburn in Belgium: Prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol 2002;14:279-84.
3. Locke GR, 3rd, Talley NJ, Feii SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-56.
4. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000;14:1589-94.
5. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology 1997;112:1798-810.
6. Myrvold HE, Lundeil L, Miettinen P, et al. The cost of long term therapy for gastro-oesophageal reflux disease: A randomised trial comparing omeprazole and open antireflux surgery. Gut 2001;49:488-94.
7. Perdikis G, Hinder RA, Lund RJ, et al. Laparoscopic Nissen fundoplication: Where do we stand? Surg Laparosc Endosc 1997;7:17-21.
8. Rantanen TK, Salo JA, Sipponen JT. Fatal and life-threatening complications in antireflux surgery: Analysis of 5,502 operations. Br J Surg 1999;86:1573-7.
9. Liu JY, Woloshin S, Laycock WS, et al. Late outcomes after laparoscopic surgery for gastroesophageal reflux. Arch Surg 2002;137:397-401.
10. Anvari M, Allen C. Five-year comprehensive outcomes evaluation in 181 patients after laparoscopic Nissen fundoplication. J Am Coll Surg 2003;196:51-7 discussion 7-8; author reply 8-9.
11. Ye W, Chow WH, Lagergren J, et al. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 2001;121:1286-93.
12. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial. JAMA 2001;285:2331-8.
13. Galmiche JP, des Varannes SB. Endoluminal therapies for gastro-oesophageal reflux disease. Lancet 2003;361:1119-21.
14. Mahmood Z, McMahon BP, Arfin Q, et al. Endocinch therapy for gastro-oesophageal reflux disease: A one year prospective follow up. Gut 2003;52:34-9.
15. Triadafilopoulos G, DiBaise JK, Nostrani TT, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 2002;55:149-56.
16. Louis H, Deviere J. Endoscopic implantation of Enteryx for the treatment of gastroesophageal reflux disease: Technique, pre-clinical and clinical experience. Gastrointest Endosc Clin N Am 2003;13:191-200.
17. Mason RJ, Hughes M, Lehman GA, et al. Endoscopic augmentation of the cardia with a biocompatible injectable polymer (Enteryx) in a porcine model. Surg Endosc 2002;16:386-91.
18. Devière J, Pastorelli A, Louis H, et al. Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: A pilot study. Gastrointest Endosc 2002;55:335-41.
19. Johnson DA, Ganz R, Aisenberg J, et al. Endoscopic, deep mural implantation of enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial. Am J Gastroenterol 2003;98:250-8.
20. Velanovich V, Vallance SR, Gusz JR, et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996;183:217-24.
21. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
22. Swanson BN. Medical use of dimethyl sulfoxide (DMSO). Rev Clin Basic Pharm 1985;5:1-33.
23. Black J. Biological performance of tantalum. Clin Mater 1994;16:167-73.
24. Matsumaru Y, Hyodo A, Nose T, et al. Embolic materials for endovascular treatment of cerebral lesions. J Biomater Sci Polym Ed 1997;8:555-69.
25. Frazzoni M, De Micheli E, Grisendi A, et al. Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: A pH-metric comparison. Aliment Pharmacol Ther 2002;16:35-9.
26. Lundell L, Backman L, Ekstrom P, et al. Prevention of relapse of reflux esophagitis after endoscopic healing: The efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991;26:248-56.
27. Sontag SJ, Kogut DG, Fleischmann R, et al. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group. Am J Gastroenterol 1996;91:1758-65.
28. Filipi CJ, Lehman GA, Rothstein RI, et al. Transoral, flexible endoscopic suturing for treatment of GERD: A multicenter trial. Gastrointest Endosc 2001;53:416-22.
29. Pessaux P, Arnaud JP, Ghavami B, et al. Morbidity of laparoscopic fundoplication for gastroesophageal reflux: A retrospective study about 1470 patients. Hepatogastroenterology 2002;49:447-50.
30. Rothstein RI, Filipi CJ. Endoscopic suturing for gastroesophageal reflux disease: Clinical outcome with the Bard EndoCinch. Gastrointest Endosc Clin N Am 2003;13:89-101.
31. Triadafilopoulos G. Clinical experience with the Stretta procedure. Gastrointest Endosc Clin N Am 2003;13:147-55.
32. Roy-Shapira A, Stein HJ, Scwartz D, et al. Endoluminal methods of treating gastroesophageal reflux disease. Dis Esophagus 2002;15:132-6.